Strides Pharma to sell majority stake in Pivot Path for Rs 100 crore to Ascent Capital-led consortium

After the transaction, Strides will hold a 19.95 per cent stake in Pivot Path, while investors will hold 65.05 per cent with ESOP Pool at 15 per cent, the filing said.